Evidence map›Paper›PMID 20211941›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2010

Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition.

Marcus J Calkins, Marcelo R Vargas, Delinda A Johnson, Jeffrey A Johnson

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Marcus J CalkinsMolecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin 53705, USA.
Marcelo R Vargas
Delinda A Johnson
Jeffrey A Johnson
Society of Environmental Toxicology and Chemistry · USPharmaceutical Biotechnology (Czechia) · CZPisgah Astronomical Research Institute · US

Funding

Molecular & Environmental Toxicology Pre-& Postdoctoral Training ProgramT32ES007015 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPHER A BRADFIELD · 1985 to 2026
$11.5M
The Nrf2-ARE pathway in modulating Parkinson's DiseaseR01ES010042 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON, JEFFREY A · 2001 to 2010
$4.0M
Transcriptional Control of Antioxidant Genes in BrainR01ES008089 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON, JEFFREY A · 2002 to 2013
$3.7M
BRAIN GLUTATHIONE S-TRANSFERASES AND NEUROTOXICITYR29ES008089 · NIEHS · UNIVERSITY OF WISCONSIN MADISON · PI JOHNSON, JEFFREY A · 1996 to 2000
$104k
NIEHS NIH HHS ES08089NIEHS NIH HHS ES10042NIEHS NIH HHS R01 ES008089NIEHS NIH HHS R01 ES010042NIEHS NIH HHS R29 ES008089NIEHS NIH HHS T32 ES007015
6 · The paper itself

Abstract

Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that is known to regulate a variety of cytoprotective genes through the antioxidant response element (ARE). This endogenous response is one of the major pathways by which cells are protected from xenobiotic or innate oxidative insults. Furthermore, in neural systems, astrocyte-specific activation of Nrf2 is known to protect neurons. In previous work, our laboratory found that Nrf2 protects from intrastriatal injections of the mitochondrial complex II inhibitor malonate. Here, we extend these results to show that multiple methods of astrocyte-specific Nrf2 overexpression provide protection from neurotoxicity in vivo. GFAP-Nrf2 transgenic mice are significantly more resistant to malonate lesioning. This outcome is associated with an increased basal resistance, but more so, an enhanced Nrf2 response to lesioning that attenuated the ensuing neurotoxicity. Furthermore, striatal transplantation of neuroprogenitor cells overexpressing Nrf2 that differentiate into astrocytes after grafting also significantly reduced malonate toxicity. Overall, these data establish that enhanced astrocytic Nrf2 response and Nrf2 preconditioning are both sufficient to protect from acute lesions from mitochondrial complex II inhibition.

Indexed as

AnimalsAstrocytesCell DifferentiationCell TransplantationCorpus StriatumEnzyme InhibitorsGene ExpressionGlutathioneMalonatesMiceMice, TransgenicMitochondriaNeuronsNF-E2-Related Factor 2RNA, MessengerStem CellsEnzyme InhibitorsGlutathioneMalonatesmalonic acidNFE2L2 protein, humanNF-E2-Related Factor 2RNA, MessengerSuccinate Dehydrogenase

Identifiers

PMID20211941
PMCPMC2871759
OpenAlexW1994387354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.